Related Experiment Videos
[Treatment strategy for malignant solid tumors in childhood]
Naomi Ohnuma1, Hideo Yoshida, Tadashi Matsunaga
1Pediatric Surgical Department, Chiba University Graduate School of Medicine, Chiba, Japan.
Nihon Geka Gakkai Zasshi
|July 28, 2005
Summary
Pediatric malignant solid tumor survival has greatly improved in Japan due to combination chemotherapy, surgery, and radiotherapy trials. Research continues to refine treatments for neuroblastoma, Wilms' tumor, and hepatoblastoma.
Area of Science:
- Pediatric oncology
- Cancer research
- Clinical trials
Context:
- Significant improvements in survival rates for children with malignant solid tumors in Japan over the past two decades.
- Sequential studies focusing on neuroblastoma, Wilms' tumor, and hepatoblastoma treatment.
- Widespread participation of institutes in nonrandomized trials.
Purpose:
- To evaluate the safety and efficacy of multimodal treatment strategies.
- To review the outcomes of combination chemotherapy, surgery, and radiotherapy.
- To identify future research directions in pediatric oncology.
Summary:
- Multicenter, nonrandomized trials in Japan have assessed combination chemotherapy, surgery, and radiotherapy for pediatric neuroblastoma, Wilms' tumor, and hepatoblastoma.
- These sequential studies have contributed to a dramatic improvement in the prognosis for affected children.
- The review of these treatment results highlights areas for further investigation.
Impact:
- Demonstrates the success of collaborative research in improving pediatric cancer survival.
- Provides a foundation for future clinical trials and treatment advancements.
- Offers insights into effective therapeutic approaches for specific childhood solid tumors.